Clinical Trial Update: A Pilot Study of Neoadjuvant Therapy With Gemcitabine and Cisplatin in Patients With Resectable or Unresectable Intrahepatic Cholangiocarcinoma [NA]

View source ↗

Summary

Pilot neoadjuvant study of gemcitabine and cisplatin in patients with resectable or unresectable intrahepatic cholangiocarcinoma was terminated, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholangiocarcinoma

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Unresectable Intrahepatic Cholangiocarcinoma, Resectable Intrahepatic Cholangiocarcinoma | NA | Status: TERMINATED | Results posted: 2016-04-13